Compounds > xanthenes
Page last updated: 2024-08-18

xanthenes and paclitaxel

xanthenes has been researched along with paclitaxel in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Henricson, BE; Li, ZY; Manthey, CL; Perera, PY; Vogel, SN1
Lee, AE; McKeage, MJ; Pruijn, FB; Shalal-Zwain, S; Siim, BG; Wilson, WR1
Elliott, JI; Higgins, CF; Raguz, S1
Davies, NM; Forrest, ML; Kwon, GS; Ohgami, Y; Remsberg, CM; Yáñez, JA1

Other Studies

4 other study(ies) available for xanthenes and paclitaxel

ArticleYear
Dissection of LPS-induced signaling pathways in murine macrophages using LPS analogs, LPS mimetics, and agents unrelated to LPS.
    Progress in clinical and biological research, 1995, Volume: 392

    Topics: Animals; Antibodies, Monoclonal; Gene Expression Regulation; In Vitro Techniques; Lipid A; Lipopolysaccharide Receptors; Lipopolysaccharides; Macrophages; Mice; Mice, Inbred C3H; Paclitaxel; Phosphoproteins; Signal Transduction; Xanthenes; Xanthones

1995
Marked potentiation of the antitumour activity of chemotherapeutic drugs by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA).
    Cancer chemotherapy and pharmacology, 2003, Volume: 51, Issue:1

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bibenzyls; Carboplatin; Dose-Response Relationship, Drug; Drug Synergism; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Paclitaxel; Stilbenes; Time Factors; Xanthenes; Xanthones

2003
Multidrug transporter activity in lymphocytes.
    British journal of pharmacology, 2004, Volume: 143, Issue:7

    Topics: Adrenergic alpha-Antagonists; Aniline Compounds; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; B-Lymphocytes; Calcium Channel Blockers; Fluoresceins; Fluorescent Dyes; Lymphocytes; Mice; Mice, Knockout; Mitoxantrone; Multidrug Resistance-Associated Proteins; Paclitaxel; Prazosin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; T-Lymphocytes; Verapamil; Xanthenes

2004
Paclitaxel prodrugs with sustained release and high solubility in poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelle nanocarriers: pharmacokinetic disposition, tolerability, and cytotoxicity.
    Pharmaceutical research, 2008, Volume: 25, Issue:1

    Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Chemical Phenomena; Chemistry, Physical; Delayed-Action Preparations; Drug Carriers; Injections, Intravenous; Male; Micelles; Nanoparticles; Octanols; Oxazines; Paclitaxel; Particle Size; Polyesters; Rats; Rats, Sprague-Dawley; Tissue Distribution; Xanthenes

2008